C. Kearon

J. Douketis, P. Prandoni, S. Middeldorp, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS)

M. O’Donnell, J. Hirsh, S. Kahn, 2008, Thrombosis and Haemostasis.

Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism

J. Hirsh, P. Brill-Edwards, M. Gent, 1998, Annals of Internal Medicine.

A normal alveolar dead space fraction plus d-dimer assay ruled out suspected pulmonary embolism in the emergency department

C. Kearon, 2001 .

Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.

S. Stevens, S. Woller, C. Kearon, 2018, Thrombosis research.

A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis.

J. Douketis, J. Hirsh, P. Brill-Edwards, 1995, Circulation.

Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis

P. Wells, M. Levine, J. Julian, 1999, Annals of Internal Medicine.

The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis.

J. Douketis, J. Hirsh, P. Brill-Edwards, 1997, Archives of internal medicine.

Use of different d‐dimer levels to exclude venous thromboembolism depending on clinical pretest probability

Jeffrey S. Ginsberg, S. Bates, C. Kearon, 2004, Journal of thrombosis and haemostasis : JTH.

Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study

J. Douketis, F. Spencer, S. Schulman, 2016, Journal of thrombosis and haemostasis : JTH.

Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

M Gent, J Bormanis, J. Hirsh, 2000, Thrombosis and Haemostasis.

Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism

J. Julian, S. Bates, C. Kearon, 2017, Thrombosis and Haemostasis.

Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

M. Gent, A. Turpie, S. Kahn, 2004 .

Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial

J. Eikelboom, S. Schulman, C. Kearon, 2014, Journal of thrombosis and haemostasis : JTH.

Excluding pulmonary embolism with helical (spiral) computed tomography: Evidence is catching up with enthusiasm.

C. Kearon, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Initial Treatment of Venous Thromboembolism

C. Kearon, 1999, Thrombosis and Haemostasis.

An approach to dyspnea in cancer patients.

K. Killian, C. Kearon, D. Fishbein, 1989, Journal of pain and symptom management.

"'Issues in Symptom Control" Part 5 An Approach to Dyspnea in Cancer Patients

K. Killian, C. Kearon, D. Fishbein, 1989 .

Starting prophylaxis for venous thromboembolism postoperatively.

J. Hirsh, C. Kearon, Jack Hirsh, 1995, Archives of internal medicine.

Early postoperative anticoagulation after mechanical valve replacement: a systematic review.

P. Wells, T. Mesana, B. Lam, 2006, The Annals of thoracic surgery.

THROMBOSIS AND HEMOSTASIS Antiphospholipid antibodies and the risk of recurrence after a fi rst episode of venous thromboembolism : a systematic review

E. Akl, C. Kearon, D. Garcia, 2013 .

Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia.

J. Hirsh, Jeffrey S. Ginsberg, C. Kearon, 1997, Archives of internal medicine.

Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta‐analysis

C. Kearon, S. Takach Lapner, S. T. Lapner, 2014, Journal of thrombosis and haemostasis : JTH.

Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10

W. Ageno, S. Kahn, P. Wells, 2010, Thrombosis and Haemostasis.

Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes

C. Kearon, Clive Kearon, 2007, Journal of thrombosis and haemostasis : JTH.

Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study

J. Douketis, P. Prandoni, M. Kovacs, 2005, Journal of thrombosis and haemostasis : JTH.

Venous thromboembolism in association with features of the metabolic syndrome.

S. Yusuf, J. Pogue, E. Lonn, 2007, QJM : monthly journal of the Association of Physicians.

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

S. Kahn, D. Anderson, P. Wells, 2021, BMJ.

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

S. Goldhaber, M. Feuring, S. Schulman, 2015, Thrombosis and Haemostasis.

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism

S. Goldhaber, M. Feuring, S. Schulman, 2016, Thrombosis and Haemostasis.

Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

S. Goldhaber, M. Feuring, S. Schulman, 2013 .

Treatment of Deep Vein Thrombosis

C. Kearon, F. Couturaud, 2001, Seminars in vascular medicine.

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

S. Goldhaber, S. Schulman, David Baanstra, 2013 .

Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated

C. Kearon, 2011, Journal of Thrombosis and Thrombolysis.

Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis.

M. Monreal, C. Kearon, H. Bounameaux, 2011, Journal of vascular surgery.

Noninvasive diagnosis of deep vein thrombosis in postoperative patients.

C. Kearon, 2001, Seminars in thrombosis and hemostasis.

Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial

S. Goldhaber, M. Jaff, A. Salter, 2019, Vascular medicine.

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome

M. Cushman, S. Kahn, M. Rodger, 2015, Journal of thrombosis and haemostasis : JTH.

Inflammation Markers and Their Trajectories after Deep Vein Thrombosis in relation to Risk of Postthrombotic Syndrome INFLAMMATION BIOMARKERS IN PTS

M. Cushman, S. Kahn, S. Solymoss, 2014 .

Definition of post‐thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization

P. Prandoni, S. Kahn, S. Vedantham, 2009, Journal of thrombosis and haemostasis : JTH.

Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials

G. Guyatt, D. Cook, K. Leslie, 2016, Anesthesiology.

Are Asymptomatic DVTs Relevant?: Response

E. Akl, C. Francis, Y. Falck‐Ytter, 2013 .

Laboratory monitoring of low‐molecular‐weight heparin therapy

C. Kearon, 2004, Journal of thrombosis and haemostasis : JTH.

Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial

S. Kahn, S. Schulman, D. T. Nguyen, 2020, Seminars in Thrombosis and Hemostasis.

Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study

J. Douketis, S. Stevens, Vinay Shah, 2019, Journal of thrombosis and haemostasis : JTH.

The American College of Chest Physicians score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: More

C. Kearon, 2019, Journal of thrombosis and haemostasis : JTH.

Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel

W. Marston, S. Goldhaber, M. Jaff, 2016, Vascular medicine.

Inter-observer reliability of the HERDOO2 clinical decision rule.

T. Ortel, D. Anderson, M. Rodger, 2016, Thrombosis research.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

J. Douketis, S. Stevens, C. Kessler, 2015, Annals of internal medicine.

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.

E. Akl, C. Kearon, 2014, Blood.

Clarification of Once-Daily Low-Molecular-Weight Heparin Dosing in Pulmonary Embolism: Response

E. Akl, C. Kearon, 2012 .

Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism

J. Julian, C. Kearon, F. Couturaud, 2001, Thrombosis and Haemostasis.

Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting

A. Iorio, G. Palareti, C. Kearon, 2010, Journal of thrombosis and haemostasis : JTH.

Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?

D. Dwivedi, P. Liaw, V. Bhagirath, 2019, Thrombosis research.

Long-term treatment of venous thromboembolism.

S. Kahn, C. Kearon, 2020, Blood.

A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II)

S. Goldhaber, S. Schulman, S. Schellong, 2011 .

Post-Hoc Analysis of RE-MEDY™ Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism

S. Goldhaber, M. Feuring, S. Schulman, 2014 .

Predictors of thrombosis in relatives of patients with venous thromboembolism

C. Kearon, F. Couturaud, 2010, Current opinion in pulmonary medicine.

Comparison of the age‐adjusted and clinical probability‐adjusted D‐dimer to exclude pulmonary embolism in the ED

C. Marriott, C. Kearon, K. de Wit, 2019, The American journal of emergency medicine.

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: reply

S. Bates, C. Kearon, S. Takach Lapner, 2018, Journal of thrombosis and haemostasis : JTH.

Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis

J. Douketis, M. Cushman, M. Marcucci, 2022, British journal of haematology.

Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review.

M. O’Donnell, J. Hirsh, J. Julian, 2003, Archives of internal medicine.

Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement

J. Douketis, M. Gent, C. Kearon, 2005, Journal of thrombosis and haemostasis : JTH.

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report - Executive Summary.

S. Stevens, P. Wells, C. King, 2021, Chest.

Safety of Withholding Heparin in Pregnant Women With a History of Venous Thromboembolism

J. Hirsh, P. Brill-Edwards, M. Gent, 2001 .

Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis

C. Kearon, 2009, Journal of thrombosis and haemostasis : JTH.

Deep vein thrombosis

M. Kovacs, J. Julian, C. Kearon, 2005, The Lancet.

Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multi-center Randomized Trial.

E. Azene, S. Goldhaber, S. Kahn, 2020, Journal of vascular and interventional radiology : JVIR.

Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in DVT Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial

E. Azene, S. Goldhaber, S. Kahn, 2020 .

Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial

S. Goldhaber, S. Kahn, T. Murphy, 2019, Thrombosis and Haemostasis.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

J. Douketis, S. Stevens, C. Kessler, 2018, Blood.

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

J. Douketis, S. Stevens, C. Kessler, 2016, Thrombosis research.

Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis?

H. Bounameaux, G. Le Gal, C. Kearon, 2015, Journal of thrombosis and haemostasis : JTH.

Other Uses of LMWHs – Miscellaneous

Paolo Prandoni, Mark Levine, Frederick R. Rickles, 1998, Pathophysiology of Haemostasis and Thrombosis.

Differences in clinical presentation of deep vein thrombosis in men and women

T. Koru-Sengul, Jeffrey S. Ginsberg, S. Bates, 2008, Journal of thrombosis and haemostasis : JTH.

Accuracy of clinical assessment of deep-vein thrombosis

Paolo Prandoni, Antonio Girolami, J. Hirsh, 1995, The Lancet.

A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism

P. Wells, M. Kovacs, K. O'rourke, 2001, British journal of haematology.

Managing challenging patients with venous thromboembolism: a practical, case-based approach.

J. Douketis, W. Ageno, C. Kearon, 2017, Polish archives of internal medicine.

Epidemiology of Venous Thromboembolism

C. Kearon, 2001, Seminars in vascular medicine.

Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature

A. Iorio, M. Marcucci, G. Palareti, 2008 .

Management of Anticoagulation in Patients Who Require Invasive Procedures

C. Kearon, 2003, Seminars in vascular medicine.

d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism

S. Stevens, J. Julian, C. Kearon, 2015, Annals of Internal Medicine.

Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study

M. O’Donnell, J. Hirsh, Jeffrey S. Ginsberg, 2003 .

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study Designer D-Dimer Deep vein thrombosis (4D) Study

F. D’Aragon, S. Kahn, M. Afilalo, 2022 .

Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism

M. Gent, P. Wells, D. Anderson, 2001, Journal of internal medicine.

Magnetic resonance direct thrombus imaging was accurate in suspected deep venous thrombosis

C. Kearon, 2002, ACP journal club.

LO55: Comparison of the age-adjusted D-dimer, clinical probability-adjusted D-dimer, and Wells rule with D-dimer for diagnosing deep vein thrombosis in the emergency department.

C. Kearon, P. Sneath, M. Eventov, 2020 .

Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.

J. Douketis, S. Schulman, J. Julian, 2012 .

Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER).

S. Kahn, M. Rodger, M. Kovacs, 2022, Thrombosis research.

Thromboembolism prevention in ischaemic stroke

M. O’Donnell, C. Kearon, 2007, The Lancet.

Risk of bleeding with vitamin K antagonists compared with low‐molecular‐weight heparin after orthopedic surgery: a rebuttal

M. O’Donnell, J. Julian, C. Kearon, 2005, Journal of thrombosis and haemostasis : JTH.

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Elie A Akl, Menno Huisman, Lisa Moores, 2012, Chest.

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial

Christina Holcroft, Mira Johri, Stan Shapiro, 2014, The Lancet.

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.

M. Gent, A. Turpie, S. Kahn, 2008, Blood.

Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial

T. Ortel, P. Wells, M. Rodger, 2013 .

Pharmacomechanical Therapy for Deep-Vein Thrombosis.

S. Goldhaber, S. Vedantham, C. Kearon, 2018, The New England journal of medicine.

Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility

S. Kahn, M. Rodger, M. Kovacs, 2021, Journal of thrombosis and haemostasis : JTH.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis

S. Goldhaber, S. Kahn, J. Julian, 2020 .

Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolism Kearon C, Ginsberg JS, Julian JA, et al. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of ve

C. Kearon, 2007 .

Optimal dose for starting and maintaining low-dose aspirin.

J. Hirsh, C. Kearon, 1993, Archives of internal medicine.

Moderate Renal Impairment and Risk of Bleeding With Anticoagulation

R. Beyth, M. Levine, S. Schulman, 2017 .

Perioperative management of long-term anticoagulation.

C. Kearon, 1999, Seminars in thrombosis and hemostasis.

Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism

C. Kearon, Clive Kearon, 2012, Current opinion in hematology.

Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.

M. O’Donnell, J. Hirsh, S. Kahn, 2006 .

Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study

G. Guyatt, M. O’Donnell, C. Kearon, 2006, The Lancet Neurology.

Evaluation of D-Dimer in the diagnosis of suspected deep-vein thrombosis

G. Kovacs, D. Anderson, P. Wells, 2004 .

Clinical Assessment and D-dimer Testing in Deep Venous Thrombosis

J. Ginsberg, C. Kearon, 2002 .

Aspirin in patients undergoing noncardiac surgery.

G. Guyatt, D. Cook, K. Leslie, 2014, The New England journal of medicine.

Long term and short term oral anticoagulation treatments were equivalent for venous thromboembolism

C. Kearon, 2002 .

3 months and 1 year of oral anticoagulant treatment were equivalent for idiopathic proximal deep venous thrombosis

C. Kearon, 2002 .

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials

Giancarlo Agnelli, Florent Boutitie, G. Raskob, 2011, BMJ : British Medical Journal.

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism

Vinay Shah, S. Kahn, D. Anderson, 2022, Blood advances.

Natural History of Venous Thromboembolism

C. Kearon, Clive Kearon, 2003, Circulation.

Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis

J. Hirsh, P. Prandoni, P. Wells, 1995 .

Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes

Pavel S. Roshanov, Julian B. T. Scott, G. Guyatt, 2014, Anesthesiology.

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply

J. Julian, S. Bates, C. Kearon, 2016, Journal of thrombosis and haemostasis : JTH.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

S. Schulman, C. Kearon, S. SCHULMAN, 2005, Journal of thrombosis and haemostasis : JTH.

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

G. Raskob, S. Kahn, G. Agnelli, 2008, Chest.

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis

G. Guyatt, E. Akl, J. Eikelboom, 2014, BMJ Open.

Management of anticoagulation before and after elective surgery.

J. Hirsh, C. Kearon, 1997, The New England journal of medicine.

Factors that predict thrombosis in relatives of patients with venous thromboembolism.

J. Douketis, S. Kahn, P. Wells, 2014, Blood.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

J. Douketis, S. Kahn, P. Wells, 2009, Chest.

Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial

G. Guyatt, D. Cook, R. Kolesar, 2013, Canadian Medical Association Journal.

Pilot trials in thrombosis: Purpose and pitfalls

N. Langlois, G. Le Gal, C. Kearon, 2018, Research and practice in thrombosis and haemostasis.

P104: Evaluating the use of the pulmonary embolism rule-out criteria in the emergency department

C. Kearon, K. Wit, P. Sneath, 2018 .

Duration of venous thromboembolism prophylaxis after surgery.

C. Kearon, 2003, Chest.

Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

S. Goldhaber, M. Jaff, D. Cohen, 2013, American heart journal.

Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial

Aaron R. Campbell, Stephen M. Mann, G. Guyatt, 2020, The Lancet.

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor

J. Douketis, J. Hirsh, M. Gent, 2004, Journal of thrombosis and haemostasis : JTH.

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

M Gent, J. Hirsh, M. Gent, 1999, The New England journal of medicine.

Thrombotic disorders: diagnosis and treatment.

M. Levine, B. Konkle, A. Schafer, 2003, Hematology. American Society of Hematology. Education Program.

Effect of warfarin on activated partial thromboplastin time in patients receiving heparin.

Jeffrey S. Ginsberg, C. Kearon, M. Johnston, 1998, Archives of internal medicine.

The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism

Jeffrey S. Ginsberg, J. Hirsh, C. Kearon, 1998, Annals of Internal Medicine.

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

G. Guyatt, M. Turiel, S. Yusuf, 2018, The Lancet.

Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE).

G. Guyatt, S. Yusuf, D. Xavier, 2018, The Canadian journal of cardiology.

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism

C. Kearon, 2007, Current opinion in pulmonary medicine.

Factors determining pulmonary function in adolescent idiopathic thoracic scoliosis.

A. Kirkley, K. Killian, C. Kearon, 1993, The American review of respiratory disease.

Factors influencing work capacity in adolescent idiopathic thoracic scoliosis.

K. Killian, C. Kearon, G. R. Viviani, 1993, The American review of respiratory disease.

Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial

J. Eikelboom, D. Sessler, M. Marcucci, 2020, Pilot and Feasibility Studies.

Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.

D. Goldstein, Jun Z. Li, P. Reitsma, 2020, Blood.

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

J. Douketis, J. Hirsh, M. Gent, 2006, JAMA.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial

L. Hofmann, S. Goldhaber, M. Jaff, 2019, Circulation.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

M. Prins, H. Büller, P. Prandoni, 2019, BMJ.

Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.

M. Crowther, Jeffrey S. Ginsberg, C. Kearon, 2000, Thrombosis research.

Perioperative management of oral anticoagulation.

M. O’Donnell, C. Kearon, 2006, Clinics in geriatric medicine.

Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism

J. Douketis, J. Hirsh, M. Gent, 2006 .

Perioperative management of oral anticoagulation.

M. O’Donnell, C. Kearon, 2006, Clinics in geriatric medicine.

Drug Trials That Have Influenced Our Practice in the Treatment of Venous Thromboembolism

C. Kearon, 1997, Thrombosis and Haemostasis.

Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery.

J. Douketis, M. Crowther, C. Kearon, 1999, Chest.

Contribution of Respiratory Muscle Oxygen Consumption to Breathing Limitation and Cyspnea

P. Casán, K. Killian, C. Kearon, 1997 .

A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism

C. Kearon, C Kearon, 2012, Journal of thrombosis and haemostasis : JTH.

Duration of Anticoagulant Therapy After Venous Thromboembolism

C. Kearon, 2010 .

Long-term management of patients after venous thromboembolism.

C. Kearon, 2004, Circulation.

Duration of therapy for acute venous thromboembolism.

C. Kearon, 2003, Clinics in chest medicine.

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

J. Douketis, Jeffrey S. Ginsberg, S. Bates, 1998, JAMA.

Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis

S. Kahn, P. Wells, M. Rodger, 2005, Journal of thrombosis and haemostasis : JTH.

Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis

S. Kahn, M. Rodger, S. Solymoss, 2018, Journal of thrombosis and haemostasis : JTH.

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.

S. Goldhaber, M. Jaff, D. Cohen, 2019, Circulation. Cardiovascular quality and outcomes.

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

S. Goldhaber, S. Schulman, S. Schellong, 2014, Circulation.

An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism

J. Douketis, P. Brill-Edwards, M. Gent, 2006, Annals of Internal Medicine.

A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography

J. Douketis, P. Brill-Edwards, M. Gent, 2005, Annals of Internal Medicine.

Physical activity in patients with deep venous thrombosis: a systematic review.

S. Kahn, I. Shrier, C. Kearon, 2008, Thrombosis research.

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

G. Raskob, W. Ageno, H. Büller, 2021, Annals of Internal Medicine.

Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis

G. Raskob, W. Ageno, H. Büller, 2021, Journal of thrombosis and haemostasis : JTH.

Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis

M. Rodger, C. Kearon, M. Carrier, 2019, Thrombosis and Haemostasis.

Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin

S. Vesely, W. Ageno, S. Kahn, 2009, Annals of Internal Medicine.

Which older emergency patients are at risk of intracranial bleeding after a fall? A protocol to derive a clinical decision rule for the emergency department

I. Stiell, M. Émond, A. Papaioannou, 2021, BMJ Open.

Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance.

Pavel S. Roshanov, G. Guyatt, A. Garg, 2020, British journal of anaesthesia.

Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

M. Gladwin, N. Desai, G. Piazza, 2019, Circulation.

Comparison of the Accuracy of Impedance Plethysmography and Compression Ultrasonography in Outpatients with Clinically Suspected Deep Vein Thrombosis

J. Hirsh, P. Prandoni, A. Cogo, 1995, Thrombosis and Haemostasis.

Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis.

L. Probyn, C. Kearon, L. Linkins, 2006, Thrombosis research.

Targeted Gene Sequencing Identifies Variants in the Protein C and Endothelial Protein C Receptor Genes in Patients With Unprovoked Venous Thromboembolism

D. Dwivedi, P. Liaw, D. Ginsburg, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial

R. Reid, S. Kahn, A. Hirsch, 2011, Canadian Medical Association Journal.

Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study.

Pavel S. Roshanov, G. Guyatt, A. Garg, 2017, CMAJ open.

Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis

K G M Moons, A. Hoes, N. Zuithoff, 2014, BMJ : British Medical Journal.

A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process

J. Hirsh, P. Prandoni, P. Wells, 1998, Journal of internal medicine.

Graduated compression stockings to treat acute leg pain associated with proximal DVT

S. Kahn, M. Rodger, S. Solymoss, 2014, Thrombosis and Haemostasis.

Meta‐analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery

C. Kearon, J. Agzarian, P. Zaręba, 2014, The British journal of surgery.

Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis.

C. Kearon, Clive Kearon, Lori-Ann Linkins, 2004, Archives of internal medicine.

Clinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis

G. Geersing, J. Elf, C. Kearon, 2019, Journal of thrombosis and haemostasis : JTH.

Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial

J. Douketis, A. Turpie, S. Kahn, 2005, The Annals of pharmacotherapy.

Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II

S. Goldhaber, M. Feuring, S. Schulman, 2014 .

Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up

S. Goldhaber, S. Schulman, David Baanstra, 2012 .

Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis

C. Bradbury, P. Prandoni, B. Hutton, 2021, Thrombosis and Haemostasis.

Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study.

Pavel S. Roshanov, G. Guyatt, A. Garg, 2020, British journal of anaesthesia.

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

J. Kaufman, S. Goldhaber, M. Jaff, 2020, Journal of vascular surgery. Venous and lymphatic disorders.

Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.

T. Gomes, D. Juurlink, M. Mamdani, 2013, The American journal of cardiology.

Factors Influencing the Reported Sensitivity and Specificity of Impedance Plethysmography for Proximal Deep Vein Thrombosis

J. Hirsh, C. Kearon, 1994, Thrombosis and Haemostasis.

Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism.

D. Dwivedi, W. Zarin, P. Liaw, 2009 .

A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D‐dimer

G. Geersing, J. Elf, T. Takada, 2021, Journal of thrombosis and haemostasis : JTH.

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

S. Kahn, D. Anderson, P. Wells, 2016 .

External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome.

S. Kahn, M. Rodger, M. Kovacs, 2022, Thrombosis and Haemostasis.

Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen: A Cohort Study

A. Worster, S. McLeod, C. Kearon, 2020, Journal of the American Geriatrics Society.

Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study

S. Kahn, M. Rodger, M. Kovacs, 2022, Thrombosis and Haemostasis.

Preoperative risk assessment for bleeding and thromboembolism

C. Kearon, D. Arnold, Julia A. M. Anderson, 2009, BMJ : British Medical Journal.

Hemorrhagic complications of anticoagulant treatment.

G. Raskob, M. Levine, C. Kearon, 2001, Chest.

Homocystine-lowering therapy and risks for venous thromboembolism: A randomized trial

J. Ray, C. Kearon, Q. Yi, 2007 .

Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes

S. Yusuf, J. Bosch, D. Xavier, 2014, Anesthesiology.

Hemorrhagic complications of anticoagulant treatment.

G. Raskob, J. Hirsh, M. Levine, 1992, Chest.

Epidemiology of postoperative venous thromboembolism: lessons from an administrative data base

C. Kearon, 2003, Thrombosis and Haemostasis.

Perioperative management of oral anticoagulation.

M. O’Donnell, C. Kearon, 2008, Cardiology clinics.

Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease

D. Goldstein, Jun Z. Li, P. Reitsma, 2017 .

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

W. Ageno, B. Cosmi, P. Kyrle, 2016, Journal of thrombosis and haemostasis : JTH.

Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.

A. Griffiths, A. Bitton, C. Bernstein, 2014, Gastroenterology.

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

M. Marcucci, G. Palareti, C. Kearon, 2010, Archives of internal medicine.

Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

G. Kovacs, D. Anderson, P. Wells, 2003, The New England journal of medicine.

Clonidine in patients undergoing noncardiac surgery.

G. Guyatt, D. Cook, K. Leslie, 2014, The New England journal of medicine.

Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

J. Hirsh, M. Gent, P. Wells, 2000, Thrombosis and Haemostasis.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

J. Douketis, S. Stevens, C. Kessler, 2015, Annals of internal medicine.

Thrombotic Disorders: Diagnosis and Treatment

B. Konkle, C. Kearon, Andrew I. Schafer, 2003 .

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS)

M. O’Donnell, J. Hirsh, S. Kahn, 2008, Thrombosis and Haemostasis.

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

F. Dentali, E. Akl, M. Gould, 2012, Chest.

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

E. Akl, S. Stevens, P. Wells, 2012, Chest.

Pharmacomechanical Therapy for Deep-Vein Thrombosis.

S. Goldhaber, S. Vedantham, C. Kearon, 2018, The New England journal of medicine.

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

S. Kahn, P. Wells, M. Rodger, 2018, Blood.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

M. Prins, H. Büller, P. Prandoni, 2019, BMJ.